| TX | HB3338 | Engross
Sine Die | Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.
[Detail][Text][Discuss] | 2023-05-24
Removed from local & uncontested calendar |
| TX | SB2527 | Engross
Sine Die | Relating to the regulation of telemedicine medical services, teledentistry services, and telehealth services; providing a civil penalty.
[Detail][Text][Discuss] | 2023-05-18
To House Public Health Committee |
| TX | HB3346 | Engross
Sine Die | Relating to the administration of medication to certain persons in the custody of a sheriff.
[Detail][Text][Discuss] | 2023-05-12
Received from the House |
| TX | HB1190 | Engross
Sine Die | Relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | HB2716 | Engross
Sine Die | Relating to neglect of a child and the grounds for termination of the parent-child relationship and possession of a child by the Department of Family and Protective Services.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | HB4059 | Engross
Sine Die | Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | HB3026 | Engross
Sine Die | Relating to the administration of a prescription drug manufacturer or third-party prescription assistance program.
[Detail][Text][Discuss] | 2023-05-10
To Senate Health & Human Services Committee |
| TX | HB2767 | Engross
Sine Die | Relating to the sharing of controlled substance prescription monitoring information between the Texas State Board of Pharmacy and the Health and Human Services Commission for the state Medicaid program.
[Detail][Text][Discuss] | 2023-05-09
To Senate Health & Human Services Committee |
| TX | SB2212 | Engross
Sine Die | Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
[Detail][Text][Discuss] | 2023-05-06
To House Public Health Committee |
| TX | HB4058 | Engross
Sine Die | Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
[Detail][Text][Discuss] | 2023-05-01
To Senate Education Committee |
| TX | SB301 | Engross
Sine Die | Relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.
[Detail][Text][Discuss] | 2023-04-28
To House Public Health Committee |
| TX | HB2891 | Engross
Sine Die | Relating to the use of glucagon medication on certain public and private school campuses.
[Detail][Text][Discuss] | 2023-04-27
To Senate Education Committee |
| TX | HB2411 | Engross
Sine Die | Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
[Detail][Text][Discuss] | 2023-04-24
To Senate Education Committee |
| TX | SB426 | Engross
Sine Die | Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
